We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+24.68%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$3.51B
AUM Growth
+$758M
Cap. Flow
+$605M
Cap. Flow %
17.25%
Top 10 Hldgs %
47.4%
Holding
285
New
108
Increased
67
Reduced
35
Closed
69

Top Buys

Rank Stock Value
1
IMDX
Insight Molecular Diagnostics
IMDX
+$28.2M
2
ALGN icon
Align Technology
ALGN
+$19.3M
3
APR
Apria, Inc. Common Stock
APR
+$17.3M
4
CUTR
Cutera, Inc.
CUTR
+$14.8M
5
CMIIU
CM Life Sciences II Inc. Unit
CMIIU
+$13M

Top Sells

Rank Stock Value
1
VCEL icon
Vericel Corp
VCEL
+$14.4M
2
AFIB
Acutus Medical Inc
AFIB
+$13.5M
3
SHC icon
Sotera Health
SHC
+$12.9M
4
OPCH icon
Option Care Health
OPCH
+$12.1M
5
BNGO icon
Bionano Genomics
BNGO
+$10.3M

Sector Composition

Rank Sector Weight
1 Healthcare 33%
2 Industrials 1.49%
3 Materials 0.46%
4 Financials 0.45%
5 Consumer Staples 0.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FULC icon
176
Fulcrum Therapeutics
FULC
$284M
$1.49M 0.04%
126,068
+70,334
+126% +$870K
HCIIU
177
DELISTED
Hudson Executive Investment Corp. II Unit
HCIIU
$1.47M 0.04%
+150,000
New +$1.56M
IDYA icon
178
IDEAYA Biosciences
IDYA
$3.56B
$1.43M 0.04%
+60,744
New +$1.17M
ALT icon
179
CALL
Altimmune
ALT
$570M
$1.41M 0.04%
+100,000
New +$1.62M
ONCR
180
DELISTED
Oncorus, Inc.
ONCR
$1.41M 0.04%
+101,264
New +$2.1M
ALPN
181
DELISTED
Alpine Immune Sciences Inc
ALPN
$1.4M 0.04%
131,981
-5,127
-4% -$63.9K
QSI icon
182
Quantum-Si Incorporated
QSI
$182M
$1.38M 0.04%
+115,477
New +$1.4M
SRRA
183
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$1.33M 0.04%
77,263
+58,323
+308% +$924K
KA
184
DELISTED
Kineta, Inc. Common Stock
KA
$1.25M 0.04%
+9,836
New +$1.33M
OBIO icon
185
Orchestra BioMed
OBIO
$266M
$1.23M 0.03%
109,492
+9,492
+9% +$116K
CMPS
186
CALL
Compass Pathways
CMPS
$1.97B
$1.1M 0.03%
+30,000
New +$1.32M
AGTC
187
DELISTED
Applied Genetic Technologies Corporation
AGTC
$1.05M 0.03%
+206,423
New +$1.07M
DTIL icon
188
Precision BioSciences
DTIL
$205M
$1.05M 0.03%
+3,370
New +$1.18M
FOLD
189
PUT
DELISTED
Amicus Therapeutics
FOLD
$1M 0.03%
101,300
-453,800
-82% -$7.02M
HCAQ
190
DELISTED
HealthCor Catalio Acquisition Corp. Class A Ordinary Shares
HCAQ
$982K 0.03%
+98,227
New +$1.01M
KRRO icon
191
CALL
Korro Bio
KRRO
$197M
$950K 0.03%
+2,000
New +$3.89M
KRRO icon
192
Korro Bio
KRRO
$197M
$950K 0.03%
+2,000
New +$3.89M
FTH
193
Faeth Therapeutics
FTH
$757M
$941K 0.03%
+3,368
New +$1.13M
GOSS icon
194
Gossamer Bio
GOSS
$86.8M
$927K 0.03%
+100,254
New +$1.01M
LVTX
195
DELISTED
LAVA Therapeutics
LVTX
$820K 0.02%
+54,000
New +$742K
VAPO
196
PUT
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$716K 0.02%
+3,725
New +$864K
TALKW
197
DELISTED
Talkspace Inc Warrant
TALKW
$659K 0.02%
+454,718
New +$921K
AUPH icon
198
Aurinia Pharmaceuticals
AUPH
$2.06B
$657K 0.02%
+50,575
New +$734K
SLDB icon
199
CALL
Solid Biosciences
SLDB
$971M
$553K 0.02%
+6,667
New +$738K
WGSWW
200
DELISTED
GeneDx Holdings Warrant
WGSWW
$525K 0.02%
+101,416
New +$564K
6 7
8
9 10

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q1 2021 Portfolio in Review

As of Q1 2021, Pura Vida Investments held 285 positions worth $3.51B, up 28% from $2.75B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Pura Vida Investments deployed $605M of net new capital in Q1 2021, opening 108 new positions and adding to 67 existing holdings. Its largest new stake was Align Technology: 35,000 shares worth $19M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 34% a quarter earlier, followed by Industrials and Materials.

On the sell side, the largest reduction was Vericel Corp, an estimated $14.4M trimmed.

  • Pura Vida Investments's largest Q1 2021 buy was Align Technology: 35,000 shares worth $19M.
  • Pura Vida Investments added most to Insight Molecular Diagnostics in Q1 2021, an estimated $28.2M increase.
  • Pura Vida Investments's biggest Q1 2021 reduction was Vericel Corp, cutting an estimated $14.4M.
  • Pura Vida Investments fully exited Acutus Medical Inc in Q1 2021, selling an estimated $13.5M.
  • Pura Vida Investments's ten largest holdings make up 47% of its $3.51B portfolio in Q1 2021.
  • Pura Vida Investments opened 108 new positions and closed 69 in Q1 2021.
  • Pura Vida Investments's portfolio value rose 28% quarter-over-quarter to $3.51B.

Based on Pura Vida Investments's 13F filing for Q1 2021, filed 12 May 2021.